Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass

被引:0
|
作者
McClung, M. R. [1 ]
Bolognese, M. A. [2 ]
Brown, J. P. [3 ,4 ]
Reginster, J-Y [5 ]
Langdahl, B. L. [6 ]
Ruiz-Santiago, N. [7 ]
Shi, Y. [7 ]
Rojeski, M. [7 ]
Timoshanko, J. [8 ]
Libanati, C. [8 ]
Kassahun, H. [7 ]
Oates, M. [7 ]
机构
[1] Oregon Osteoporosis Ctr, Portland, OR USA
[2] Bethesda Hlth Res Ctr, Bethesda, MD USA
[3] Laval Univ, Quebec City, PQ G1K 7P4, Canada
[4] CHU Quebec CHUL, Res Ctr, Quebec City, PQ, Canada
[5] Univ Liege, Liege, Belgium
[6] Aarhus Univ Hosp, Aarhus, Denmark
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
[8] UCB Pharma, Anderlecht, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-642
引用
下载
收藏
页码:246 / 247
页数:2
相关论文
共 50 条
  • [1] ROMOSOZUMAB AFTER DENOSUMAB IMPROVES LUMBAR SPINE AND MAINTAINS TOTAL HIP BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS
    McClung, M. R.
    Bolognese, M. A.
    Brown, J. P.
    Reginster, J. -Y.
    Langdahl, B. L.
    Ruiz-Santiago, N.
    Shi, Y.
    Rojeski, M.
    Timoshanko, J.
    Libanati, C.
    Kassahun, H.
    Oates, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S41 - S42
  • [2] Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass
    McClung, Michael R.
    Bolognese, Michael A.
    Brown, Jacques P.
    Reginster, Jean-Yves
    Langdahl, Bente
    Ruiz-Santiago, Norma
    Shi, Yifei
    Rojeski, Maria
    Timoshanko, Jen
    Libanati, Cesar
    Kassahun, Helina
    Oates, Mary
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Strength at the Lumbar Spine and Hip Improves with Romosozumab Compared with Teriparatide in Postmenopausal Women with Low Bone Mass
    Keaveny, T. M.
    Crittenden, D. B.
    Bolognese, M. A.
    Genant, H. K.
    Engelke, K.
    Oliveri, B.
    Brown, J. P.
    Langdahl, B. L.
    Yang, Y. C.
    Grauer, A.
    Libanati, C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
    Genant, Harry K.
    Engelke, Klaus
    Bolognese, Michael A.
    Mautalen, Carlos
    Brown, Jacques P.
    Recknor, Chris
    Goemaere, Stefan
    Fuerst, Thomas
    Yang, Yu-Ching
    Grauer, Andreas
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (01) : 181 - 187
  • [5] Romosozumab in postmenopausal women with low bone mineral density
    Schurman, Leon
    ACTUALIZACIONES EN OSTEOLOGIA, 2014, 10 (02) : 206 - 208
  • [6] Romosozumab in Postmenopausal Women with Low Bone Mineral Density
    McClung, Michael R.
    Grauer, Andreas
    Boonen, Steven
    Bolognese, Michael A.
    Brown, Jacques P.
    Diez-Perez, Adolfo
    Langdahl, Bente L.
    Reginster, Jean-Yves
    Zanchetta, Jose R.
    Wasserman, Scott M.
    Katz, Leonid
    Maddox, Judy
    Yang, Yu-Ching
    Libanati, Cesar
    Bone, Henry G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 412 - 420
  • [7] Romosozumab in postmenopausal women with low bone mineral density
    Tornero Marin, C.
    REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 345 - 345
  • [8] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [9] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [10] Denosumab in postmenopausal women with low bone mineral density
    Charles L. Loprinzi
    Current Oncology Reports, 2006, 8 (4) : 267 - 268